ArticleBritish journal of haematology2026

Daratumumab, bortezomib and dexamethasone for previously treated myeloma-Real-world outcomes for 2545 patients treated in England.

Sarah L Lawton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.